click below
click below
Normal Size Small Size show me how
Antineoplastic Drugs
Antineoplastic Drug Classes and Mechanisms
| Question | Answer |
|---|---|
| Antimetabolites | cell cycle specific (s-phase): interfere with DNA and/or protein synthesis |
| Antimitotics (general) | cell cycle specific (m-phase): prevents microtubules from forming and breaking down |
| Topoisomerase I inhibitors | cell cycle non-specific: binds to topoisomerase I which prevents its binding to DNA; results in increased torsional strain and eventually causes DNA breaks |
| Topoisomerase II inhibitors | cell cycle non-specific: binds to topoisomerase II while topoisomerase II is bound to DNA; allows DNA strand break but prevents resealing |
| Anthracyclines | cell cycle non-specific: topoisomerase II inhibitors, produce oxygen free radicals, intercalates into DNA |
| Alkylating Agents | cell cycle non-specific: covalently binds reactive alkyl groups to nucleic acids, can result in crosslinking of DNA (intrastrand, interstrand) |
| Heavy Metals | cell cycle non-specific: platinum binds to DNA and chases its shape and reactivity |
| Biologics: Tyrosine Kinase Inhibitors | cell cycle non-specific: create pro-growth signals in some cancer cells, inhibition of these enzymes block cell growth and induces apoptosis |
| Biologics: Monoclonal Antibodies | cell cycle non-specific: antibody dependent lysis (label), complement dependent lysis (label), localized delivery of radiation, localized delivery of chemotherapy, inhibit angiogenesis |
| Antimitotics: Vinca Alkaloids | cell cycle specific (prometaphase): inhibits spindle fiber formation by binding tubulin |
| Antimitotics: Taxanes | cell cycle specific (prevents anaphase to telophase conversion): stabilizes microtubules, prevents them from breaking down |
| Antimitotics: Eribulin | cell cycle specific (prevents anaphase to telophase conversion): stabilizes microtubules, prevents them from breaking down |